Signal active
Organization
Contact Information
Overview
Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.
Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.
Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food & beverage, cosmetic, therapeutic, and agricultural industries.
About
Biotechnology, Food and Beverage, GreenTech, Sustainability, Therapeutics, Animal Feed, Cosmetics
2018
11-50
Headquarters locations
Australia, Oceania
Social
N/A
Profile Resume
Provectus Algae headquartered in Australia, Oceania, operates in the Biotechnology, Food and Beverage, GreenTech, Sustainability, Therapeutics, Animal Feed, Cosmetics sector. The company focuses on Biotechnology and has secured $1.2B in funding across 84 round(s). With a team of 11-50 employees, Provectus Algae is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Provectus Algae, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
1
0
$14.7M
Details
2
Provectus Algae has raised a total of $14.7M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | 3.3M | ||
2021 | Seed | 11.4M |
Investors
Provectus Algae is funded by 17 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Provectus Algae | - | FUNDING ROUND - Provectus Algae | 11.4M |
Acequia Capital (AceCap) | - | FUNDING ROUND - Acequia Capital (AceCap) | 11.4M |
Provectus Algae | - | FUNDING ROUND - Provectus Algae | undefined |
CJ BIO | - | FUNDING ROUND - CJ BIO | undefined |
Recent Activity
There is no recent news or activity for this profile.